Publications by authors named "Ernst Ulsperger"

19Publications

Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines.

Cancers (Basel) 2019 Jan 19;11(1). Epub 2019 Jan 19.

Department of Vascular Surgery, Medical University of Vienna, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11010114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357007PMC
January 2019

How to target small cell lung cancer.

Oncoscience 2015 21;2(8):684-92. Epub 2015 Aug 21.

Ludwig Boltzmann Cluster of Translational Oncology, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580060PMC
http://dx.doi.org/10.18632/oncoscience.212DOI Listing
October 2015

Docetaxel in the treatment of non-small cell lung cancer (NSCLC) -- an observational study focusing on symptom improvement.

Anticancer Res 2013 Sep;33(9):3831-6

Medical University of Innsbruck, Department of Internal Medicine V, Anichstrasse 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
September 2013

Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer.

Anticancer Res 2011 Sep;31(9):2949-55

Medical University of Innsbruck, Department of Internal Medicine V/ Haematology and Oncology, Anichstrasse 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
September 2011

In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines.

Clin Transl Oncol 2011 Jan;13(1):43-9

Department of Internal Medicine I, Division of Oncology, St. Poelten Hospital, St. Poelten, Austria.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12094-011-0615-z
Publisher Site
http://dx.doi.org/10.1007/s12094-011-0615-zDOI Listing
January 2011

Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells.

J Exp Pharmacol 2011 1;3:43-50. Epub 2011 Apr 1.

Ludwig Boltzmann Institute of Clinical Oncology and Photodynamic Therapy, Ludwig Boltzmann Cluster of Translational Oncology, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/JEP.S13630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863305PMC
May 2016

In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds.

Clin Pharmacol 2010 14;2:177-83. Epub 2010 Sep 14.

Ludwig Boltzmann Cluster of Translational Oncology, Ludwig Boltzmann Society, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CPAA.S11795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262384PMC
June 2012

Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.

Ann Hematol 2010 Mar 20;89(3):273-82. Epub 2009 Aug 20.

Department Internal Medicine 3, Centre for Hematology and Medical Oncology, General Hospital Linz, Krankenhausstrasse 9, 4020, Linz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-009-0811-xDOI Listing
March 2010

In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent.

Met Based Drugs 2009 30;2009:348916. Epub 2009 Jun 30.

Ludwig Boltzmann Cluster Translational Oncology, Operngasse 6/5, 1010 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2009/348916DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705772PMC
July 2011

Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.

Int J Oncol 2006 Oct;29(4):973-80

Department of Internal Medicine IV, Hepatology and Gastroenterology, University of Heidelberg, D-69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
October 2006